EC Number |
Inhibitors |
Structure |
---|
5.3.3.1 | (17S)-Spiro[5alpha-androstane-17,2'-oxiran]-3-one |
potent irreversible active-site directed |
|
5.3.3.1 | (17S)-Spiro[estra-1,3,5(10),6,8-pentaene-17,2'-oxiran]-3-ol |
active-site-directed, irreversible |
|
5.3.3.1 | (17S)-Spiro[estra-1,3,5(10)-triene-17,2'-oxiran]-3-ol |
potent irreversible active-site directed |
|
5.3.3.1 | (3S)-Spiro-[5alpha-androstane-3,2'-oxiran]-17-one |
- |
|
5.3.3.1 | 10beta-(1-Oxoprop-2-ynyl)oestr-4-ene-3,17-dione |
irreversible, time-dependent, active-site directed |
|
5.3.3.1 | 17-beta-Acetoxy-5alpha-androstan-3-one |
- |
|
5.3.3.1 | 17beta-(1-Oxoprop-2-ynyl)androst-4-en-3-one |
irreversible, time-dependent, active-site directed |
|
5.3.3.1 | 17beta-estradiol |
competitive |
|
5.3.3.1 | 17beta-estradiol |
IC50: 0.0003 mM |
|
5.3.3.1 | 17beta-Hydroxy-5,10-seco-oestr-4-yne-3,10-dione |
irreversible, time-dependent, active-site directed |
|